Sp1 and c-Myc regulate transcription of BMI1 in nasopharyngeal carcinoma (Q45376660)

13 December 2017

title

Sp1 and c-Myc regulate transcription of BMI1 in nasopharyngeal carcinoma (English)

1 reference

13 December 2017

Hong-Bo Wang

1

1 reference

13 December 2017

Gui-Hong Liu

2

1 reference

13 December 2017

Hua Zhang

3

1 reference

13 December 2017

Shan Xing

4

1 reference

13 December 2017

Li-Juan Hu

5

1 reference

13 December 2017

Wei-Feng Zhao

6

1 reference

13 December 2017

Bo Xie

7

1 reference

13 December 2017

Man-Zhi Li

8

1 reference

13 December 2017

Bo-Hang Zeng

9

1 reference

13 December 2017

Yingqiu Li

10

1 reference

13 December 2017

Mu-Sheng Zeng

11

1 reference

13 December 2017

language of work or name

English

0 references

publication date

24 May 2013

1 reference

13 December 2017

1 reference

13 December 2017

volume

280

1 reference

13 December 2017

issue

12

1 reference

13 December 2017

page(s)

2929-2944

1 reference

Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Bmi1, stem cells, and senescence regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

FoxM1c counteracts oxidative stress-induced senescence and stimulates Bmi-1 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Bmi-1 Regulation of INK4A-ARF Is a Downstream Requirement for Transformation of Hematopoietic Progenitors by E2a-Pbx1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Targeted depletion of BMI1 sensitizes tumor cells to P53-mediated apoptosis in response to radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

RAC1 activation mediates Twist1-induced cancer cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Regulation of the potential marker for intestinal cells, Bmi1, by β-catenin and the zinc finger protein KLF4: implications for colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Bmi-1 is induced by the Epstein-Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Sonic hedgehog regulates Bmi1 in human medulloblastoma brain tumor-initiating cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

c-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Focus on nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1Bbeta and TSLC1 in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Combined treatment of pancreatic cancer with mithramycin A and tolfenamic acid promotes Sp1 degradation and synergistic antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Sp transcription factor family and its role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

The role of Sp1 and Sp3 in normal and cancer cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Sp1 activation of a TATA-less promoter requires a species-specific interaction involving transcription factor IID.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

LEDGF/p75 TATA-less promoter is driven by the transcription factor Sp1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Sp1 and Sp3 regulate basal transcription of the human APOBEC3G gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Identifying synergistic regulation involving c-Myc and sp1 in human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Treatment of osteolytic myelomatosis with mithramycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

βTrCP regulates BMI1 protein turnover via ubiquitination and degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Deletion analysis of BMI1 oncoprotein identifies its negative regulatory domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Identification of a polymorphism in the RING finger of human Bmi-1 that causes its degradation by the ubiquitin-proteasome system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Sp1 and Sp3 are involved in the full transcriptional activity of centromere protein H in human nasopharyngeal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12299

21 January 2018

Identifiers

DOI

10.1111/FEBS.12299

1 reference

13 December 2017

1 reference